Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose

Applied Physiology, Nutrition and Metabolism

Volumn 34, Issue 2, 2009, Pages 136-142

  Liu, Jian ^a   Joshi, Divya ^a   Sempos, Christopher T ^b  

^a BROCK UNIVERSITY   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adolescents; Impaired fasting glucose; Metabolic risk factors; NHANES; Non HDL

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY; RISK; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; WAIST CIRCUMFERENCE;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; ODDS RATIO; PREDIABETIC STATE; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; UNITED STATES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 66149109612     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H08-149     Document Type: Article

References (29)

1. Botero, D., and Wolfsdorf, J.I. 2005. Diabetes mellitus in children and adolescents. Arch. Med. Res. 36: 281-290. doi:10.1016/j. arcmed.2004.12.002. PMID:15925018.
2. Box, G.C. 1964. An analysis of transformations. J. R. Stat. Soc. Ser. B, 26: 211-252.
3. Center for Disease Control and Prevention (CDC). 2008a. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey data. US Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, Md.
4. CDC. 2008b. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). US Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, Md.
5. Cui, Y., Blumenthal, R.S., Flaws, J.A., Whiteman, M.K., Langenberg, P., Bachorik, P.S., et al. 2001. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch. Intern. Med. 161: 1413-1419. doi:10.1001/ archinte.161.11.1413. PMID:11386890.
6. Daniels, S.R., and Greer, F.R. 2008. Lipid screening and cardiovascular health in childhood. Pediatrics, 122: 198-208. doi:10.1542/ peds.2008-1349. PMID:18596007.
7. Duncan, G.E. 2006. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch. Pediatr. Adolesc. Med. 160: 523-528. doi:10.1001/archpedi.160.5.523. PMID:16651496.
8. Ford, E.S., and Li, C. 2008. Defining the metabolic syndrome in children and adolescents: Will the real definition please stand up? J. Pediatr. 152: 160-164. doi:10.1016/j.jpeds.2007.07.056. PMID:18206681.
9. Ford, E.S., Mokdad, A.H., and Ajani, U.A. 2004. Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics, 114: 1534-1544. doi:10. 1542/peds.2004-0674. PMID:15574612.
10. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502. PMID:4337382.
11. Frost, P.H., and Havel, R.J. 1998. Rationale for use of non-highdensity lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.. Am. J. Cardiol. 81(4A): 26B-31B. PMID:9526810.
12. Genuth, S., Alberti, K.G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., et al. 2003. The expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26: 3329-3330. doi:10.2337/diacare.26.12.3331. PMID:14578240.
13. Ginsberg, H.N., Zhang, Y.L., and Hernandez-Ono, A. 2006. Metabolic syndrome: focus on dyslipidemia. Obesity (Silver Spring), 14: 41S-49S. doi:10.1038/oby.2006.281. PMID:16642962.
14. Goodman, E., Dolan, L.M., Morrison, J.A., and Daniels, S.R. 2005. Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation, 111: 1970-1977. doi:10.1161/01.CIR.0000161957.34198. 2B. PMID:15837951.
15. Goodman, E., Daniels, S.R., Meigs, J.B., and Dolan, L.M. 2007. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation, 115: 2316-2322. doi:10.1161/ CIRCULATIONAHA.106.669994. PMID:17420347.
16. Gregg, E.W., Cheng, Y.J., Cadwell, B.L., Imperatore, G., Williams, D.E., Flegal, K.M., et al. 2005. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA, 293: 1868-1874. doi:10.1001/jama.293.15.1868. PMID:15840861.
17. Grundy, S.M. 2001. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target. Arch. Intern. Med. 161: 1379-1380. doi:10.1001/archinte.161.11.1379. PMID:11386886.
18. Grundy, S.M. 2002. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation, 105: 2696-2698. doi:10.1161/01. CIR.0000020650.86137.84. PMID:12057978.
19. Jiang, R., Schulze, M.B., Li, T., Rifai, N., Stampfer, M.J., Rimm, E.B., et al. 2004. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care, 27: 1991-1997. doi:10.2337/diacare.27. 8.1991. PMID:15277429.
20. Jolliffe, C.J., and Janssen, I. 2006. Distribution of lipoproteins by age and gender in adolescents. Circulation, 114: 1056-1062. doi:10. 1161/CIRCULATIONAHA.106.620864. PMID:16940191.
21. Jolliffe, C.J., and Janssen, I. 2007. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J. Am. Coll. Cardiol. 49: 891-898. doi:10.1016/j.jacc. 2006.08.065. PMID:17320748.
22. Liu, J., Sempos, C., Donahue, R.P., Dorn, J., Trevisan, M., and Grundy, S.M. 2005. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care, 28: 1916-1921. doi:10.2337/diacare.28.8.1916. PMID:16043732.
23. Liu, J., Sempos, C.T., Donahue, R.P., Dorn, J., Trevisan, M., and Grundy, S.M. 2006. Non-high-density lipoprotein and very-lowdensity lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am. J. Cardiol. 98: 1363-1368. doi:10. 1016/j.amjcard.2006.06.032. PMID:17134630.
24. Liu, J., Wade, T.J., and Tan, H. 2007. Cardiovascular risk factors and anthropometric measurements of adolescent body composition: a cross-sectional analysis of the Third National Health and Nutrition Examination Survey. Int. J. Obes. (Lond.). 31: 59-64. doi:10.1038/sj.ijo.0803347. PMID:16652133.
25. Lu, W., Resnick, H.E., Jablonski, K.A., Jones, K.L., Jain, A.K., Howard, W.J., et al. 2003. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care, 26: 16-23. doi:10.2337/diacare.26.1.16. PMID:12502653.
26. NCEP ATP III. 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285: 2486-2497. doi:10.1001/jama.285.19.2486. PMID:11368702.
27. Siegel, R.D., Cupples, A., Schaefer, E.J., and Wilson, P.W. 1996. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism, 45: 1267-1272. doi:10.1016/S0026-0495(96)90246-2. PMID:8843183.
28. Williams, C.L., Hayman, L.L., Daniels, S.R., Robinson, T.N., Steinberger, J., Paridon, S., et al. 2002. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 106: 143-160. doi:10.1161/01.CIR.0000019555.61092.9E. PMID:12093785.
29. Williams, D.E., Cadwell, B.L., Cheng, Y.J., Cowie, C.C., Gregg, E.W., Geiss, L.S., et al. 2005. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics, 116: 1122-1126. doi:10.1542/peds.2004-2001. PMID:16263998.